GENE Total Utang marang Modal GTG Labs

Lambang korporat lan logo GTG Labs (GENE)

The growth of Genetic Technologies (GENE) relies on recognition by insurance structures and the legalization of preventive diagnostics. This daily price chart from GURU.Markets shows the metric at 0.48, which is attributed to a profit deficit and the expenditure of capital on molecular research. However, the implementation of cloud AI for mass screening will allow for a manifold reduction in genome processing costs, ensuring high business scalability.

Rasio Utang marang Ekuitas: Genetic Technologies Ltd (GENE) kanggo 04.07.2022 - 26.10.2024

Rincian analitis lan laporan data perusahaan Genetic Technologies Limited (GENE)

- rega lan prakiraan konsensus rega:
Bagan rega Genetic Technologies Ltd|GENE - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Genetic Technologies|GENE - Total Nilai Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham Genetic Technologies|GENE - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku gtglabs.com|GENE - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Genetic Technologies|GENE - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Genetic Technologies Ltd|GENE - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Genetic Technologies|GENE - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Genetic Technologies
Ringkesan analisis perusahaan:GENE, Genetic Technologies
Produk mawa merek Genetic Technologies Limited

The leverage dynamics reflect the financial stability of Genetic Technologies as it scales predictive genetic testing and integrates PRS analysis into medicine. This ratio is calculated as total liabilities to equity, allowing investors to assess the business's dependence on borrowed funds and determine the balance between high leverage risk and capital efficiency.

Analisis perusahaan pesaing

Utang marang Ekuitas A|Rasio Total Utang marang Ekuitas Quest Diagnostics Inc.|Illumina Corp - Total Utang marang Modal|Utang marang Modal Exact Sciences Inc. (EXAS)|RVTY - Total Utang marang Modal|Rasio Utang marang Ekuitas bio-rad.com BIO|Anbio - Total Utang marang Modal|SHC: Total Utang marang Modal|Utang marang Ekuitas QuidelOrtho Corp|OPKO Health Corp. (OPK) - Rasio Utang marang Ekuitas|CDNA (CareDx Inc) - Total Utang marang Modal|Total Utang marang Modal MRVI|Utang marang Ekuitas Fulgent Genetics (FLGT)|Utang marang Ekuitas Standard BioTools Inc LAB|CTKB: Rasio Total Utang marang Ekuitas|OraSure Corp - Utang marang Modal|Utang marang Ekuitas XGN (Exagen Diagnostics)|MDXH - Koefisien Total Utang marang Modal|Lucid Diagnostics - Total Utang marang Modal|PRE (Prenetics) - Koefisien Total Utang marang Modal|IMDX: Utang marang Ekuitas|Koefisien Total Utang marang Modal Trinity Biotech Corp|PRPH: Total Utang marang Modal|Rasio Utang marang Modal ainos.com (AIMD)|CODX: Total Utang marang Modal|Heart Test Laboratories, Inc. - Utang marang Modal|Biomerica, Inc (BMRA) - Utang marang Ekuitas|CDIO - Rasio Utang marang Ekuitas|Total Utang marang Modal VRAX|Utang marang Modal bluejaydx.com|Aspira Women's Health Inc. (AWH) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Accelerate Diagnostics Inc.|CNTG (CENTOGENE, N.V.) - Total Utang marang Modal|Koefisien Total Utang marang Modal enzo.com (ENZ)|Fresh2 Group - Total Utang marang Modal|ME - Rasio Total Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Psychemedics Corporation (PMD)